94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
Yue Wang1,2†Ying Li3†Liang Wang2Buze Chen4Miaolin Zhu5Chunyi Ma2Chunyan Mu1,2Aibin Tao6
Shibao Li1,2,3
Lan Luo1,2
Ping Ma1,2
Shuai Ji7*
Ting Lan1,2*- 1Xuzhou Key Laboratory of Laboratory Diagnostics, Xuzhou Medical University, Xuzhou, China
- 2School of Medical Technology, Xuzhou Medical University, Xuzhou, China
- 3Department of Laboratory Medicine, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- 4Department of Gynecology, Affiliated Hospital of Xuzhou Medical University, Xuzhou, China
- 5Department of Pathology, Jiangsu Cancer Hospital, Nanjing, China
- 6Division of Cardiology, Department of Medicine, The Affiliated People’s Hospital of Jiangsu University, Zhenjiang, China
- 7School of Pharmacy, Xuzhou Medical University, Xuzhou, China
A Corrigendum on
Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway
by Wang Y, Li Y, Wang L, Chen B, Zhu M, Ma C, Mu C, Tao A, Li S, Luo L, Ma P, Ji S and Lan T (2022). Front. Pharmacol. 13:779608. doi: 10.3389/fphar.2022.779608
In the published article, there was an error in Figure 3 as published. The 5 μg/mL CA DAPI and the 10 μg/mL CA Merge got mixed up in Figure 3D. The corrected Figure 3 appear below.
Figure 3
Figure 3. CA reverses the EGF-induced EMT process in A2780 and SKOV3 cells in vitro. (A) Cell morphology of A2780 and SKOV3 after CA and EGF treatment. (B) Expression of E-cadherin, N-cadherin, vimentin, and Snail were detected by Western blotting in A2780 and SKOV3 cells after CA and EGF treatment. Representative fluorescence images of E-cadherin (C) and N-cadherin (D) in A2780 and SKOV3 cells. At least three independent experiments were performed.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Keywords: cinnamaldehyde, epithelial-to-mesenchymal transformation, PI3K/AKT, ovarian cancer, proliferation, metastasis
Citation: Wang Y, Li Y, Wang L, Chen B, Zhu M, Ma C, Mu C, Tao A, Li S, Luo L, Ma P, Ji S and Lan T (2024) Corrigendum: Cinnamaldehyde suppressed EGF-induced EMT process and inhibits ovarian cancer progression through PI3K/AKT pathway. Front. Pharmacol. 15:1427330. doi: 10.3389/fphar.2024.1427330
Received: 03 May 2024; Accepted: 21 June 2024;
Published: 08 July 2024.
Edited and reviewed by:
Ricky Yuet-Kin Leung, University of Arkansas for Medical Sciences, United StatesCopyright © 2024 Wang, Li, Wang, Chen, Zhu, Ma, Mu, Tao, Li, Luo, Ma, Ji and Lan. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Shuai Ji, amlzaHVhaTAxMTVAeHpobXUuZWR1LmNu; Ting Lan, dGluZ2xhbkB4emhtdS5lZHUuY24=
†These authors have contributed equally to this work